Welcome to our dedicated page for Babcock & Wilcox Enterprises SEC filings (Ticker: BWSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Babcock & Wilcox Enterprises's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Babcock & Wilcox Enterprises's regulatory disclosures and financial reporting.
Babcock & Wilcox Enterprises, Inc. furnished a press release announcing its financial results for the quarter ended June 30, 2025 and attached that release as Exhibit 99.1. The company also posted an investor presentation on its investor relations website at www.babcock.com, attached as Exhibit 99.2. The filing states that the information in those exhibits is furnished and expressly not to be treated as "filed" or incorporated by reference in other registrations or reports except by specific reference. No financial figures or analysis are included in this 8-K itself; readers must consult the attached exhibits for details.
Babcock & Wilcox Enterprises, Inc. (BWSN) submitted a Form 144 reporting a proposed sale of 2,915 shares of common stock, with an aggregate market value of $3,906.00, to be sold approximately on 08/08/2025 through Charles Schwab & Co., Inc. on the NYSE. The securities were recorded as acquired on 08/05/2025 by a restricted stock lapse and the filing lists the payment type as equity compensation.
The filing also discloses a recent sale by the same account of 2,551 shares on 07/31/2025 for $2,364.00, and reports total shares outstanding of 98,404,024. The filer signs a representation that they do not possess undisclosed material adverse information about the issuer.